Danaher could announce Masimo acquisition as early as Tuesday, FT reports Danaher valued at over $150 billion, Masimo at $7 billion Danaher previously acquired Abcam for $5.7 billion in 2023 Danaher ...

Masimo manufactures medical monitoring devices, including pulse oximeters, and had accused Apple Inc (NASDAQ: AAPL) of infringing on its intellectual property. Danaher has been on an aggressive ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Danaher has struck an almost $10bn deal to buy patient monitoring company Masimo, two years after an activist ...

Danaher (DHR) is nearing a roughly $10 billion deal to acquire U.S. medical technology firm Masimo (MASI), the Financial Times reported, citing people familiar with the matter. A deal for the ...

・Masimo is undergoing an organizational realignment to sharpen its focus on core healthcare offerings. ・A U.S. jury ordered Apple to pay Masimo $634 million in damages in the patent infringement case; ...

Feb 16 (Reuters) - Life sciences firm Danaher is closing in on a nearly $10 billion deal to acquire pulse oximeter maker Masimo, the Financial Times reported on Monday, citing sources. Danaher and ...